Advaxis, Inc. Gains 18.65%
Wed, May 19, 2021 at 05:33 PM
Advaxis, Inc. (ADXS:NASDAQ) soared at $0.58, a gain of 18.6%. On Tue, May 18, 2021, ADXS:NASDAQ hit a New 2-Week High of $0.49. The stock appeared on our News Catalysts scanner on Wed, Apr 28, 2021 at 04:52 PM in the 'BIOTECH' category. From Tue, May 04, 2021, the stock recorded 40.00% Up Days and 45.45% Green Days
The stock spiked on Wed, Feb 17, 2021 at $1.57 with a volume of 50M+, and its share price has been moving sideways in recent weeks.
About Advaxis, Inc. (ADXS:NASDAQ)
Advaxis Inc focuses on discovery, development, and commercialization of proprietary Lm (Listeria monocytogenes)-LLO (Listeriolysin O) cancer immunotherapies.
Top 10 Gainers:
- MoSys, Inc. (MOSY:NASDAQ), 44.06%
- Lianluo Smart Limited (LLIT:NASDAQ), 24.59%
- Reata Pharmaceuticals, Inc. (RETA:NASDAQ), 23.78%
- VERA (VERA:NASDAQ), 23.56%
- Advaxis, Inc. (ADXS:NASDAQ), 18.65%
- Acasti Pharma Inc. (ACST:NASDAQ), 18%
- Transcat, Inc. (TRNS:NASDAQ), 17.95%
- Home Federal Bancorp, Inc. of Louisiana (HFBL:NASDAQ), 17.92%
- HyreCar Inc. (HYRE:NASDAQ), 17.61%
- LFMD (LFMD:NASDAQ), 16.59%